Brain Health Made
Accessible
Objective
Brain Health Diagnosis, at Any
Point of Care
Making an Impact
Delphi-MD empowers neurologists, point of care physicians, healthcare systems and preventative care programs with real time, accurate clinical insights for early diagnosis of brain abnormalities. Delphi-MD produces actionable recommendations to help patients receive better care and reduce the massive financial burden associated with brain health care.
Physicians
Healthcare Systems
Health Plans
A Wide Range of Diagnostic Value
Delphi-MD was granted FDA Breakthrough designation status twice, for 2 clinical indications.
The first is for the detection of early functional and structural brain abnormalities that indicate the early progression of stroke and dementia. And the second for accurately diagnosing NPH (Normal Pressure Hydrocephalus) and predicting the effectiveness of a shunt implant treatment (VPS).
Normal Pressure Hydrocephalus
Vascular Dementia
Alzheimer's Disease
Stroke
Lewy Body Dementia
Parkinson's Disease
Traumatic Brain Injury
Why Delphi-MD?
Scientifically
validated
Objective reading of brain network health
Early and differential
diagnosis
Easy to use in any
clinical setting
Highly accurate,
real-time results
Provides a clinical
actionable report
Safe, non-invasive and
radiation free
Accessible and
cost-effective
How Does It Work?
· Trusted Partners ·
Confidence Through Evidence
Early diagnosis of Dementia
Frontiers 2021
Delphi enables the early diagnosis of Dementia. Fogel et al.; Dementia and Neurodegeneration.
Delphi detects white matter changes indicating StrokeTBI
Delphi-MD and aging
Frontiers 2019
Delphi Diagnosis of Abnormal Aging. Zifman et al; Frontiers in Aging Neuroscience.
Want to See It in Action?
